Cargando…
Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
BACKGROUND: Between 8% and 22% of female carriers of DMD mutations exhibit clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers without chromosomal rearrangements has been attributed to skewed X-chromosome inactivation (XCI) favouring predominant expression of the...
Autores principales: | Juan-Mateu, Jonàs, Rodríguez, Maria José, Nascimento, Andrés, Jiménez-Mallebrera, Cecilia, González-Quereda, Lidia, Rivas, Eloy, Paradas, Carmen, Madruga, Marcos, Sánchez-Ayaso, Pedro, Jou, Cristina, González-Mera, Laura, Munell, Francina, Roig-Quilis, Manuel, Rabasa, Maria, Hernández-Lain, Aurelio, Díaz-Manera, Jorge, Gallardo, Eduard, Pascual, Jordi, Verdura, Edgard, Colomer, Jaume, Baiget, Montserrat, Olivé, Montse, Gallano, Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492175/ https://www.ncbi.nlm.nih.gov/pubmed/23092449 http://dx.doi.org/10.1186/1750-1172-7-82 |
Ejemplares similares
-
Interplay between DMD Point Mutations and Splicing Signals in Dystrophinopathy Phenotypes
por: Juan-Mateu, Jonàs, et al.
Publicado: (2013) -
DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations
por: Juan-Mateu, Jonas, et al.
Publicado: (2015) -
Dystrophinopathy Phenotypes and Modifying Factors in
DMD
Exon 45–55 Deletion
por: Poyatos‐García, Javier, et al.
Publicado: (2022) -
Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency
por: Domínguez-González, Cristina, et al.
Publicado: (2021) -
Late-Onset Dystrophinopathy
por: Singh, Ranjan K
Publicado: (2021)